Patrick W Allender

CIK 1205268 · Executive VP · last filed 2026-10-05

Patrick W Allender is an Executive VP who has filed 227 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider was granted $160.0K of BRC on Oct 5, 2026. Across all open-market trades the lifetime net is −$28.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.7M across reported positions. 70 SEC filings were submitted jointly with Enovis CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$15.74M

Companies

Total Filings

227

Lifetime Open-Market Net

-$28.51M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

6555 W. GOOD HOPE RD
MILWAUKEE, WI 53223

Related Filers

Enovis CORP — 70 joint filings, latest 2022-01-04

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BRC	Director	108,062	$84.41	$9.12M	$461.7K	124	2026-10-05
ESAB	Director	13,145	$64.88	$852.8K	-$118.5K	24	2026-04-01
Enovis CORP (CFXA) Delisted	Director	161,925	$177.71	$28.78M	$0	15	2022-01-04
DBD	Director	73,809	$63.02	$4.65M	$296.7K	9	2019-04-29
Enovis CORP (CFX) Delisted	Director	24,953	$117.18	$2.92M	$455.4K	52	2019-01-03
XRAY	Executive VP	128,615	$8.69	$1.12M	-$29.60M	2	2007-02-02

Recent Filings

227 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-10-05	BRC	Grant (A)	+1,878	$160.0K	EDGAR
2026-07-06	BRC	Grant (A)	+267	$24.5K	EDGAR
2026-04-07	BRC	Grant (A)	+304	$24.4K	EDGAR
2026-04-01	ESAB	Grant (A)	—	$0	EDGAR
2026-01-12	BRC	Grant (A)	+296	$24.3K	EDGAR
2026-01-05	ESAB	Grant (A)	—	$0	EDGAR
2025-10-15	BRC	Grant (A)	+373	$27.7K	EDGAR
2025-10-06	BRC	Grant (A)	+1,728	$135.1K	EDGAR
2025-10-01	ESAB	Grant (A)	—	$0	EDGAR
2025-07-08	BRC	Grant (A)	+427	$29.4K	EDGAR

Showing 1–10 of 227

Page 1 of 23 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.